News
GLP-1 Weight Loss Drugs Cut Alcohol Cravings By Two-Thirds
GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to cravings for alcohol, said senior researcher Dr. Carel le Roux, chair of experimental pathology at University College Dublin in Ireland.
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...
Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...
Researchers also found that about one-third of teens undergoing weight-loss surgery had a body mass index (BMI) of more than ...
New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the ...
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback